282 related articles for article (PubMed ID: 1090366)
1. Selection for high immunogenicity in drug-resistant sublines of murine lymphomas demonstrated by plaque assay.
Fuji H; Mihich E
Cancer Res; 1975 Apr; 35(4):946-52. PubMed ID: 1090366
[TBL] [Abstract][Full Text] [Related]
2. Differential tumor immunogenicity of L1210 and its sublines. I. Effect of an increased antigen density on tumor cell surfaces on primary B cell responses in vitro.
Fuji H; Mihich E; Pressman D
J Immunol; 1977 Sep; 119(3):983-6. PubMed ID: 330761
[TBL] [Abstract][Full Text] [Related]
3. Differential antigenic expression of the DBA/2 lymphoma L1210 and its sublines: cross-reactivity with C3H mammary tumors as defined by syngeneic monoclonal antibodies.
Rapp L; Fuji H
Cancer Res; 1983 Jun; 43(6):2592-9. PubMed ID: 6342755
[TBL] [Abstract][Full Text] [Related]
4. Monoclonal antibody-recognizing tumor-associated antigen of DBA/2 mouse lymphoma L1210 and its sublines.
Fuji H
Transplant Proc; 1980 Sep; 12(3):388-90. PubMed ID: 6784299
[TBL] [Abstract][Full Text] [Related]
5. Differential tumor immunogenicity of DBA/2 mouse lymphoma L1210 and its sublines. III. Control of host resistance to drug-resistant L1210 sublines by H-2-linked and non-H-2-linked genes.
Fuji H; Murakami M
J Natl Cancer Inst; 1983 Jan; 70(1):119-25. PubMed ID: 6296515
[TBL] [Abstract][Full Text] [Related]
6. Monoclonal antibodies to the L1210 murine leukemia cell line and to a drug-altered subline.
Testorelli C; Archetti YL; Aresca P; Del Vecchio L
Cancer Res; 1985 Nov; 45(11 Pt 1):5299-303. PubMed ID: 4053006
[TBL] [Abstract][Full Text] [Related]
7. Differences in the immunogenicity of leukemia L1210 sublines in DBA-2 mice.
Mihich E; Kitano M
Cancer Res; 1971 Dec; 31(12):1999-2003. PubMed ID: 5120297
[No Abstract] [Full Text] [Related]
8. Differential expression of murine leukemia antigen on L1210 parental and drug-resistant sublines.
Strzadala L; Opolski A; Radzikowski C; Mihich E
Cancer Res; 1981 Dec; 41(12 Pt 1):4934-7. PubMed ID: 7306993
[TBL] [Abstract][Full Text] [Related]
9. Tumor-specific idiotype vaccines. I. Generation and characterization of internal image tumor antigen.
Raychaudhuri S; Saeki Y; Fuji H; Kohler H
J Immunol; 1986 Sep; 137(5):1743-9. PubMed ID: 3018080
[TBL] [Abstract][Full Text] [Related]
10. Differential tumor immunogenicity of DBA/2 mouse lymphoma L1210 and its sublines. II. Increased expression of tumor-associated antigens on subline cells recognized by serologic and transplantation methods.
Fuji H; Mihich E; Pressman D
J Natl Cancer Inst; 1979 Jun; 62(6):1503-10. PubMed ID: 286122
[No Abstract] [Full Text] [Related]
11. Clonal variation in tumorigenicity of L1210 lymphoma cells: nontumorigenic variants with an enhanced expression of tumor-associated antigen and Ia antigens.
Fuji H; Iribe H
Cancer Res; 1986 Nov; 46(11):5541-7. PubMed ID: 3489524
[TBL] [Abstract][Full Text] [Related]
12. Antigenic differences between leukemia L1210 and a subline resistant to methylglyoxal-bis(guanylhydrazone).
Kitano M; Mihich E; Pressman D
Cancer Res; 1972 Feb; 32(2):181-6. PubMed ID: 5061638
[No Abstract] [Full Text] [Related]
13. Immunosensitivity and histocompatibility antigens in drug-altered leukemic cells.
Nicolin A; Franco P; Testorelli C; Goldin A
Cancer Res; 1976 Jan; 36(1):222-7. PubMed ID: 1248001
[TBL] [Abstract][Full Text] [Related]
14. [Pharmacological alteration of the antigenic properties of experimental leukemias detected by lymphocyte transformation].
Testorelli C; Missiroli A; Di Padova F; Nicolin A
Boll Ist Sieroter Milan; 1976; 55(2):142-50. PubMed ID: 1023882
[TBL] [Abstract][Full Text] [Related]
15. Serological analysis of H-2 antigens expression on the cell surface of drug- and lectin-resistant mouse tumor cells.
Opolski A; Duś D; Radzikowski C
Arch Immunol Ther Exp (Warsz); 1986; 34(1):21-34. PubMed ID: 3778114
[TBL] [Abstract][Full Text] [Related]
16. A new antigen in leukemia L1210 subline (resistant to methylglyoxal-bis-guanylhydrazone).
Kitano M
Bull Chest Dis Res Inst Kyoto Univ; 1974 Mar; 7(2):126-34. PubMed ID: 4411685
[No Abstract] [Full Text] [Related]
17. Analysis of the idiotypic network in tumor immunity.
Raychaudhuri S; Saeki Y; Chen JJ; Kohler H
J Immunol; 1987 Dec; 139(11):3902-10. PubMed ID: 2824616
[TBL] [Abstract][Full Text] [Related]
18. [Mechanism of action and resistance of antineoplastic agents].
Tanaka N
Gan To Kagaku Ryoho; 1983 Nov; 10(11):2245-51. PubMed ID: 6195971
[TBL] [Abstract][Full Text] [Related]
19. Participation of T-lymphocytes in the curative effect of a novel synthetic polyamine analogue, N,N'-bis[3-(ethylamino)propyl]-1,7-heptanediamine, against L1210 leukemia in vivo.
Bowlin TL; Prakash NJ; Edwards ML; Sjoerdsma A
Cancer Res; 1991 Jan; 51(1):62-6. PubMed ID: 1988107
[TBL] [Abstract][Full Text] [Related]
20. Antigenicity of L1210 leukemic sublines induced by drugs.
Nicolin A; Vadlamudi S; Goldin A
Cancer Res; 1972 Apr; 32(4):653-7. PubMed ID: 5014777
[No Abstract] [Full Text] [Related]
[Next] [New Search]
